Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
188.00
-8.3 (-4.23%)
BSENSE

Mar 16

BSE+NSE Vol: 43.67 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "188.00",
    "chg": -8.3,
    "chgp": "-4.23%",
    "dir": -1,
    "prev_price": "196.30",
    "mcapval": "1,795.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE873D01024",
    "curr_date": "Mar 16",
    "curr_time": "",
    "bse_nse_vol": "43.67 k",
    "exc_status": "Active",
    "traded_date": "Mar 16, 2026",
    "traded_date_str": "2026 03 16",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.188.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-falls-to-52-week-low-of-rs1889-3894232",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3894232.png",
        "date": "2026-03-16 14:06:24",
        "description": "Indoco Remedies Ltd has reached a new 52-week low, with its stock price dropping to Rs.188.9 today, marking a significant decline amid broader market pressures and company-specific financial concerns."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3886725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_mojoScore_3886725.png",
        "date": "2026-03-12 10:10:18",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.189.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-falls-to-52-week-low-of-rs18925-3880016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3880016.png",
        "date": "2026-03-09 12:35:50",
        "description": "Indoco Remedies Ltd’s share price declined sharply to a fresh 52-week low of Rs.189.25 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent challenges faced by the company amid a broader market downturn and sector-specific pressures."
      },
      {
        "title": "Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.194.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-falls-to-52-week-low-of-rs1944-3870083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3870083.png",
        "date": "2026-03-04 14:10:45",
        "description": "Indoco Remedies Ltd’s stock declined to a fresh 52-week low of Rs.194.4 today, marking a significant milestone in its ongoing downward trajectory. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges that have weighed on investor sentiment and overall performance."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3863085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_mojoScore_3863085.png",
        "date": "2026-03-01 10:10:14",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3845613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_mojoScore_3845613.png",
        "date": "2026-02-18 10:10:25",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 December 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 18 February 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Indoco Remedies Ltd’s Volatile Week: 11.01% Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltds-volatile-week-1101-surge-amid-mixed-technical-signals-3826504",
        "imagepath": "",
        "date": "2026-02-07 16:10:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens weak at Rs.211.60, down 2.67%</p>\n                    <p><strong>3 Feb:</strong> Intraday high of Rs.245.45 with 11.01% surge</p>\n                    <p><strong>4 Feb:</strong> Price momentum shifts with 10.11% gain amid mixed technical signals</p>\n                    <p><strong>5 Feb:</strong> Bearish momentum returns, stock declines 0.29%</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.213.75, down 4.89% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.217.40</div></div>\n                    <di..."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3825802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_mojoScore_3825802.png",
        "date": "2026-02-07 10:10:19",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 December 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 07 February 2026, providing investors with the latest data to understand the stock’s standing today."
      },
      {
        "title": "Why is Indoco Remedies Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indoco-remedies-ltd-fallingrising-3825402",
        "imagepath": "",
        "date": "2026-02-07 00:40:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Indoco Remedies has experienced a steady downward trajectory over recent sessions, with the stock falling for three consecutive days and losing nearly 9.75% in that period. Despite an intraday high of Rs 229.45, the stock ultimately traded closer to its intraday low of Rs 212, indicating selling pressure. The weighted average price suggests that a larger volume of shares exchanged hands near the lower price point, reinforcing bearish momentum. Additionally, the stock exhibited high volatility today, with intraday fluctuations of 5.29%, underscoring uncertainty among traders.</p>\n<p>From a technical standpoint, Indoco Remedies is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day average..."
      }
    ],
    "total": 539,
    "sid": "601817",
    "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-Mar-2026",
      "details": "Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company will be participating in the 11th Annual Valorem Conference-Resilient Corporates Relentless India organised by Valorem Advisors .",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "24-Feb-2026",
      "details": "Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution 10mg/mL",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "09-Feb-2026",
      "details": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Conclusion of Search by GST Authorities",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Indoco Remedies Ltd’s Volatile Week: 11.01% Surge Amid Mixed Technical Signals

2026-02-07 16:10:23

Key Events This Week

2 Feb: Stock opens weak at Rs.211.60, down 2.67%

3 Feb: Intraday high of Rs.245.45 with 11.01% surge

4 Feb: Price momentum shifts with 10.11% gain amid mixed technical signals

5 Feb: Bearish momentum returns, stock declines 0.29%

6 Feb: Week closes at Rs.213.75, down 4.89% on the day

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

13-Mar-2026 | Source : BSE

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company will be participating in the 11th Annual Valorem Conference-Resilient Corporates Relentless India organised by Valorem Advisors .

Announcement under Regulation 30 (LODR)-Press Release / Media Release

24-Feb-2026 | Source : BSE

Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution 10mg/mL

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015

09-Feb-2026 | Source : BSE

Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Conclusion of Search by GST Authorities

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Indoco Remedies Ltd has declared 10% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12

stock-summary
BONUS

Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12

stock-summary
RIGHTS

No Rights history available